Cargando…
Discovery, development, and future application of senolytics: theories and predictions
Senescent cells accumulate with aging and at etiological sites of multiple diseases, including those accounting for most morbidity, mortality, and health costs. Senescent cells do not replicate, can release factors that cause tissue dysfunction, and yet remain viable. The discovery of senolytic drug...
Autores principales: | Wissler Gerdes, Erin O., Zhu, Yi, Tchkonia, Tamar, Kirkland, James L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302972/ https://www.ncbi.nlm.nih.gov/pubmed/32112672 http://dx.doi.org/10.1111/febs.15264 |
Ejemplares similares
-
Senolytic drugs: from discovery to translation
por: Kirkland, J. L., et al.
Publicado: (2020) -
The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene
por: Hoffman, Eric P.
Publicado: (2020) -
Senolytics: Potential for Alleviating Diabetes and Its Complications
por: Palmer, Allyson K, et al.
Publicado: (2021) -
Development of a novel senolytic by precise disruption of FOXO4-p53 complex
por: Tripathi, Utkarsh, et al.
Publicado: (2021) -
ORALLY ACTIVE, CLINICALLY TRANSLATABLE SENOLYTICS RESTORE Α-KLOTHO IN MICE AND HUMANS
por: Zhu, Yi, et al.
Publicado: (2022)